Thromboxane B2 in borderline and essential hypertensive patients.
暂无分享,去创建一个
J. Levenson | M. Safar | G. London | J. Bariéty | A. Simon | A. Hornych
[1] R. Ardaillou,et al. In vitro prostaglandin synthesis by human glomeruli and papillae. , 1982, Prostaglandins.
[2] J. Bariéty,et al. Radioimmunoassay measurement of thromboxane B2 in human plasma and urine. , 1982, Prostaglandins, leukotrienes, and medicine.
[3] G. MacGregor,et al. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. , 1980, Kidney international.
[4] M. Mitchell,et al. Presence of thromboxane B2 and 6-keto-prostaglandin F1 alpha in the urine of fetal sheep. , 1979, Prostaglandins and medicine.
[5] J. Vane,et al. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. , 1978, Pharmacological reviews.
[6] P. Needleman,et al. Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney , 1977, Nature.
[7] B. Samuelsson,et al. Radioimmunoassay for Thromboxane B2 , 1976 .
[8] M. Hamberg,et al. Prostaglandin endoperoxides. VII. Novel transformations of arachidonic acid in guinea pig lung. , 1974, Biochemical and biophysical research communications.
[9] R. Frackowiak,et al. Cardiopulmonary blood volume in borderline hypertension. , 1974, Clinical science and molecular medicine.
[10] W. Goldring,et al. EFFECTIVE RENAL BLOOD FLOW IN SUBJECTS WITH ESSENTIAL HYPERTENSION. , 1941, The Journal of clinical investigation.